These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2572145)

  • 1. A double-blind, placebo-controlled study of alpidem, a novel anxiolytic of imidazopyridine structure, in chronically anxious patients.
    Casacchia M; Farolfi A; Priore P; Magni G; Stratta P; Cesana B; Rossi A
    Acta Psychiatr Scand; 1989 Aug; 80(2):137-41. PubMed ID: 2572145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of alpidem in anxious elderly outpatients: a double-blind, placebo-controlled trial.
    Frattola L; Piolti R; Bassi S; Albizzati MG; Cesana BM; Bottani MS; Priore P; Borghi C; Morselli PL
    Clin Neuropharmacol; 1992 Dec; 15(6):477-87. PubMed ID: 1362137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double blind, controlled study of the efficacy and safety of alpidem in the treatment of anxiety in schizophrenic in-patients.
    Minervini MG; Priore P; Farolfi A; Cesana B; Morselli PL
    Pharmacopsychiatry; 1990 Mar; 23(2):102-6. PubMed ID: 1971117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpidem, a novel anxiolytic drug. A double-blind, placebo-controlled study in anxious outpatients.
    Bassi S; Albizzati MG; Ferrarese C; Frattola L; Cesana B; Piolti R; Farolfi A
    Clin Neuropharmacol; 1989 Feb; 12(1):67-74. PubMed ID: 2565767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical studies with the new anxiolytic alpidem in anxious patients: an overview of the European experiences.
    Musch B; Morselli PL; Priore P
    Pharmacol Biochem Behav; 1988 Apr; 29(4):803-6. PubMed ID: 2901120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Double-blind versus placebo comparison of single dose alpidem (50 mg or 75 mg) in a model of situational anxiety].
    Regnier F; Chastel A; L'Heritier C; Magni G; Henry M
    Therapie; 1989; 44(4):279-83. PubMed ID: 2574502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpidem and lorazepam in the treatment of patients with anxiety disorders: comparison of physiological and psychological effects.
    Morton S; Lader M
    Pharmacopsychiatry; 1992 Jul; 25(4):177-81. PubMed ID: 1356277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the therapeutic action of alpidem in anxiety disorders: an overview of the European data.
    Morselli PL
    Pharmacopsychiatry; 1990 May; 23 Suppl 3():129-34. PubMed ID: 1974073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of alpidem, a nonbenzodiazepine, and lorazepam in patients with nonpsychotic anxiety.
    Diamond BI; Nguyen H; O'Neal E; Ochs R; Kaffeman M; Borison RL
    Psychopharmacol Bull; 1991; 27(1):67-71. PubMed ID: 1677774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies with alpidem in normal volunteers and anxious patients.
    Morton S; Lader M
    Pharmacopsychiatry; 1990 May; 23 Suppl 3():120-3. PubMed ID: 1974071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
    Naukkarinen H; Raassina R; Penttinen J; Ahokas A; Jokinen R; Koponen H; Lepola U; Kanerva H; Lehtonen L; Pohjalainen T; Partanen A; Mäki-Ikola O; Rouru J;
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):617-23. PubMed ID: 15949921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of the anxiolytic SC 48,274 in generalized anxiety disorder (GAD).
    Cutler NR; Sramek JJ; Macpherson AE; Doss MG; Benes CO; Howard SF
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jul; 18(4):685-94. PubMed ID: 7938559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of alpidem and placebo in relieving benzodiazepine withdrawal symptoms.
    Lader M; Farr I; Morton S
    Int Clin Psychopharmacol; 1993; 8(1):31-6. PubMed ID: 8097214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial.
    Gelenberg AJ; Lydiard RB; Rudolph RL; Aguiar L; Haskins JT; Salinas E
    JAMA; 2000 Jun; 283(23):3082-8. PubMed ID: 10865302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the efficacy, safety and withdrawal of alpidem and alprazolam in anxious patients.
    Frattola L; Garreau M; Piolti R; Bassi S; Albizzati MG; Borghi C; Morselli PL
    Br J Psychiatry; 1994 Jul; 165(1):94-100. PubMed ID: 7802852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone.
    Pollack MH; Worthington JJ; Manfro GG; Otto MW; Zucker BG
    J Clin Psychiatry; 1997; 58 Suppl 11():19-23. PubMed ID: 9363044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot study of alpidem, a new nonbenzodiazepine anxiolytic, in the treatment of generalized anxiety disorder.
    Schweizer E; Csanalosi I; Rickels K
    J Clin Psychopharmacol; 1988 Feb; 8(1):74. PubMed ID: 2895127
    [No Abstract]   [Full Text] [Related]  

  • 18. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
    Cutler NR; Sramek JJ; Keppel Hesselink JM; Krol A; Roeschen J; Rickels K; Schweizer E
    J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpidem in the treatment of panic disorder.
    Schneier FR; Carrasco JL; Hollander E; Campeas R; Fallon B; Saoud JB; Feerick J; Liebowitz MR
    J Clin Psychopharmacol; 1993 Apr; 13(2):150-3. PubMed ID: 8096527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of pregabalin in elderly people with generalised anxiety disorder.
    Montgomery S; Chatamra K; Pauer L; Whalen E; Baldinetti F
    Br J Psychiatry; 2008 Nov; 193(5):389-94. PubMed ID: 18978320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.